The development of oncology therapeutics relies heavily on specialized intermediates—molecules that serve as critical building blocks in the synthesis of anti-cancer drugs. Among these, N-(2-methoxy-5-nitrophenyl)acetamide (CAS: 33721-54-9) has attracted...
